Nomura K, Puett D W, Puett D, Shizume K, Liddle G W
Department of Medicine, Vanderbilt University, Nashville, Tennessee.
Acta Endocrinol (Copenh). 1989 Oct;121(4):587-94. doi: 10.1530/acta.0.1210587.
LH is composed of isoforms which exhibit microheterogeneity. We recently demonstrated that a particular ovine or porcine LH preparation (G100-fr.3) stimulates kidney growth. This study was conducted to clarify the physiological role of this renotropic activity and other extragonadal effects of the ovine LH preparation in CD-1 mice. Hypophysectomy caused a significantly greater reduction in relative dry kidney weight (i.e. g/100 g body weight) when compared to adrenalectomy, castration, thyroidectomy, and castration plus thyroidectomy. Supplementation with G100-fr.3 in these animals partially restored not only kidney size but also DNA, RNA and protein content. Treatment with standard LH preparations (NIDDKoLH24 and G3-268DA), as well as PRL, GH, FSH and TSH, failed to reverse the renal atrophy induced by hypophysectomy and castration. Administration of testosterone to castrated hypophysectomized mice increased kidney weight and RNA content, but not renal DNA. The relative dry kidney weight increased significantly at the onset of puberty in intact male mice, but not in castrated males or intact female mice. In addition, human CG increased kidney size in hypophysectomized male mice, but not in castrated hypophysectomized animals. These findings indicate that LH isoforms may regulate kidney growth in the male mouse both directly as a renotropin stimulating hyperplasia and indirectly as a gonadotropin via testicular androgen, producing cellular hypertrophy. It was also noted that G100-fr.3 decreased hepatic weight, DNA, RNA and protein, but produced no significant change in the spleen, heart or adrenal glands in castrated-hypophysectomized mice. Such extragonadal effects of G100-fr.3 were also observed in intact female mice. These results suggest that certain LH isoforms may have extragonadal actions involving the kidney and liver.
促黄体生成素(LH)由表现出微异质性的同工型组成。我们最近证明,一种特定的绵羊或猪促黄体生成素制剂(G100-fr.3)可刺激肾脏生长。本研究旨在阐明这种促肾活性以及绵羊促黄体生成素制剂在CD-1小鼠中的其他性腺外作用的生理作用。与肾上腺切除术、去势、甲状腺切除术以及去势加甲状腺切除术相比,垂体切除术导致相对肾脏干重(即克/100克体重)的降低更为显著。在这些动物中补充G100-fr.3不仅部分恢复了肾脏大小,还恢复了DNA、RNA和蛋白质含量。用标准促黄体生成素制剂(NIDDKoLH24和G3-268DA)以及催乳素、生长激素、促卵泡生成素和促甲状腺激素进行治疗,未能逆转垂体切除术和去势诱导的肾萎缩。给去势的垂体切除小鼠注射睾酮可增加肾脏重量和RNA含量,但对肾脏DNA无影响。完整雄性小鼠在青春期开始时相对肾脏干重显著增加,但去势雄性小鼠或完整雌性小鼠则无此现象。此外,人绒毛膜促性腺激素(hCG)可增加垂体切除雄性小鼠的肾脏大小,但对去势的垂体切除动物无效。这些发现表明,促黄体生成素同工型可能直接作为一种促肾素刺激增生来调节雄性小鼠的肾脏生长,也可能通过睾丸雄激素作为一种促性腺激素间接调节,从而产生细胞肥大。还注意到,G100-fr.3可降低去势垂体切除小鼠的肝脏重量、DNA、RNA和蛋白质含量,但对脾脏、心脏或肾上腺无显著影响。在完整雌性小鼠中也观察到了G100-fr.3的这种性腺外作用。这些结果表明,某些促黄体生成素同工型可能具有涉及肾脏和肝脏的性腺外作用。